Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$755M |
| 2 |
Uber
UBER
|
+$510M |
| 3 |
DexCom
DXCM
|
+$469M |
| 4 |
Autodesk
ADSK
|
+$317M |
| 5 |
Meta Platforms (Facebook)
META
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.34B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
PayPal
PYPL
|
+$635M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$470M |
| 5 |
QuantumScape Corp
QS
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.51% |
| 2 | Healthcare | 19.12% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Financials | 10.38% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECOM
526
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $54.4M | 0.02% |
2,311,019
+11,776
| +0.5% | +$260K |
|
527
Itron
ITRI
$4.48B
| $54.2M | 0.02% |
611,776
-199,121
| -25% | -$19.7M |
|
528
Driven Brands
DRVN
$2.47B
| $54.2M | 0.02% |
+2,133,636
| New | +$60.5M |
|
529
Royalty Pharma
RPRX
$26.2B
| $54.1M | 0.02% |
1,240,054
-3,661,646
| -75% | -$174M |
|
530
Mondelez International
MDLZ
$82.9B
| $53.9M | 0.02% |
920,438
+213,126
| +30% | +$12M |
|
|
ACCD
531
DELISTED
Accolade Inc
ACCD
| $53.8M | 0.02% |
1,186,658
+224,648
| +23% | +$10.8M |
|
532
Champion Homes
SKY
$4.41B
| $53.8M | 0.02% |
1,189,255
+329,046
| +38% | +$13.2M |
|
533
Lyft
LYFT
$5.86B
| $53.1M | 0.02% |
840,546
+820,446
| +4,082% | +$45.8M |
|
534
Ambarella
AMBA
$3.04B
| $52.7M | 0.02% |
525,811
-414,407
| -44% | -$45.1M |
|
535
BioAtla
BCAB
$5.34M
| $52.5M | 0.02% |
20,648
-5,676
| -22% | -$14.5M |
|
|
CSII
536
DELISTED
Cardiovascular Systems, Inc.
CSII
| $52.5M | 0.02% |
1,369,000
-311
| -0% | -$13.2K |
|
|
CCC
537
CCC Intelligent Solutions
CCC
$3.55B
| $52.3M | 0.02% |
+5,156,480
| New | +$62.5M |
|
538
Bio-Rad Laboratories Class A
BIO
$8.76B
| $52.3M | 0.02% |
91,524
+34,635
| +61% | +$20.5M |
|
539
Sotera Health
SHC
$5B
| $52.2M | 0.02% |
2,092,926
-1,411,424
| -40% | -$37.3M |
|
540
Criteo S.A. Ordinary Shares
CRTO
$1.14B
| $51.8M | 0.02% |
1,490,003
-424,672
| -22% | -$11.7M |
|
541
ExxonMobil
XOM
$650B
| $51.8M | 0.02% |
927,249
-85,907
| -8% | -$4.5M |
|
|
KSU
542
DELISTED
Kansas City Southern
KSU
| $51.6M | 0.02% |
195,675
-216,160
| -52% | -$47M |
|
543
Graphic Packaging
GPK
$3.35B
| $51.6M | 0.02% |
2,841,246
-647,978
| -19% | -$11.1M |
|
544
Churchill Downs
CHDN
$6.17B
| $51.2M | 0.02% |
450,702
-85,752
| -16% | -$9.44M |
|
545
DuPont de Nemours
DD
$18.6B
| $51.1M | 0.02% |
526,678
+204,834
| +64% | +$19.6M |
|
546
4D Molecular Therapeutics
FDMT
$502M
| $50.7M | 0.02% |
1,227,397
+205,486
| +20% | +$9.1M |
|
|
BCYC
547
Bicycle Therapeutics
BCYC
$269M
| $50.7M | 0.02% |
+1,693,658
| New | +$43.7M |
|
548
Corteva
CTVA
$60.5B
| $50.6M | 0.02% |
1,084,782
-61,418
| -5% | -$2.72M |
|
549
Fox Class B
FOX
$22.1B
| $50.2M | 0.02% |
1,436,600
-529,917
| -27% | -$17.8M |
|
550
Xcel Energy
XEL
$49.2B
| $50.1M | 0.02% |
753,660
-540,862
| -42% | -$34.2M |
|
Similar funds
Janus Henderson Group's Q1 2021 Portfolio in Review
As of Q1 2021, Janus Henderson Group held 1,666 positions worth $219B, up 1.8% from $215B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group's Q1 2021 filing shows 289 new, 589 increased, 627 reduced and 113 closed positions. Its largest new stake was Ferguson: 6,188,608 shares worth $740M. The largest sale was Salesforce, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2021 buy was Ferguson: 6,188,608 shares worth $740M.
- Janus Henderson Group added most to Uber in Q1 2021, an estimated $510M increase.
- Janus Henderson Group's biggest Q1 2021 reduction was Salesforce, cutting an estimated $1.34B.
- Janus Henderson Group fully exited Lumentum in Q1 2021, selling an estimated $91.1M.
- Janus Henderson Group's ten largest holdings make up 22% of its $219B portfolio in Q1 2021.
- Janus Henderson Group opened 289 new positions and closed 113 in Q1 2021.
- Janus Henderson Group's portfolio value rose 1.8% quarter-over-quarter to $219B.
Based on Janus Henderson Group's 13F filing for Q1 2021, filed 17 May 2021.